Meeder Asset Management Inc. purchased a new stake in shares of USANA Health Sciences, Inc. (NYSE:USNA – Free Report) in the 4th quarter, Holdings Channel.com reports. The firm purchased 3,988 shares of the company’s stock, valued at approximately $143,000.
A number of other large investors have also added to or reduced their stakes in the company. Martingale Asset Management L P boosted its position in shares of USANA Health Sciences by 2.1% during the 3rd quarter. Martingale Asset Management L P now owns 16,732 shares of the company’s stock valued at $634,000 after acquiring an additional 340 shares during the last quarter. R Squared Ltd bought a new position in USANA Health Sciences during the fourth quarter valued at $28,000. Safe Harbor Fiduciary LLC purchased a new position in shares of USANA Health Sciences in the 3rd quarter worth $30,000. Exchange Traded Concepts LLC grew its stake in shares of USANA Health Sciences by 11.3% in the 4th quarter. Exchange Traded Concepts LLC now owns 8,578 shares of the company’s stock worth $308,000 after buying an additional 869 shares in the last quarter. Finally, Principal Financial Group Inc. increased its holdings in shares of USANA Health Sciences by 2.8% in the 4th quarter. Principal Financial Group Inc. now owns 53,603 shares of the company’s stock worth $1,924,000 after buying an additional 1,480 shares during the last quarter. Institutional investors own 54.25% of the company’s stock.
Analyst Ratings Changes
USNA has been the subject of several recent research reports. Sidoti lowered USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 18th. StockNews.com cut USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a report on Friday, February 14th. Finally, DA Davidson decreased their price target on USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating on the stock in a report on Thursday, February 27th.
USANA Health Sciences Trading Down 2.9 %
USNA stock opened at $26.98 on Tuesday. The stock has a market cap of $510.06 million, a PE ratio of 9.53, a P/E/G ratio of 0.93 and a beta of 0.98. USANA Health Sciences, Inc. has a 12 month low of $26.19 and a 12 month high of $49.78. The company has a 50-day moving average price of $31.01 and a 200 day moving average price of $34.98.
USANA Health Sciences (NYSE:USNA – Get Free Report) last announced its earnings results on Tuesday, February 25th. The company reported $0.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.49 by $0.15. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The business had revenue of $213.61 million during the quarter, compared to analyst estimates of $208.82 million. Sell-side analysts forecast that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.
Insiders Place Their Bets
In related news, insider David Mulham Mulham sold 3,234 shares of the business’s stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $32.98, for a total value of $106,657.32. Following the completion of the sale, the insider now owns 12,775 shares in the company, valued at approximately $421,319.50. The trade was a 20.20 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Joshua Foukas sold 5,732 shares of the firm’s stock in a transaction on Wednesday, March 12th. The stock was sold at an average price of $32.54, for a total value of $186,519.28. The disclosure for this sale can be found here. Insiders have sold a total of 15,920 shares of company stock worth $500,285 over the last quarter. Company insiders own 0.33% of the company’s stock.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
See Also
- Five stocks we like better than USANA Health Sciences
- Trading Stocks: RSI and Why it’s Useful
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- How to trade penny stocks: A step-by-step guide
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA – Free Report).
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.